The March/April issue of Retina Specialist is out now! Inside, experts cover topics such as the impact of anti-VEGF biosimilars, pearls for port delivery system refills, gene therapy for nAMD, a rundown on Eylea HD & more.
Read at Retina-Specialist.com
#retina #retina specialist

José Luis Cárdenas at #BiosimilarsLatAm - #Colombia2024 , stressed a multi-criteria approach over price-centricity. It ensures healthcare systems and patients benefit fully from #biosimilars , fostering sustainable supply and better outcomes.

📚 Dive into 'Biosimilars for the Management of Eye Conditions' with Medscape's FDA-developed CE course! Equip yourself to discuss the benefits of #biosimilars with patients with ophthalmologic conditions. Start learning now: bit.ly/3IL6f6M

In 2021, European markets saw a significant rise in biosimilar medicines, reaching €9.7Bn and accounting for 37% of total biologics in treatment days. Explore further insights in our report on Unlocking Biosimilar Potential: bit.ly/4d1poPN. #Biosimilars 💊📈

US to see surge in new obesity drug launches in next five years

🌟 A heartfelt thank you to all the incredible participants of #BiosimilarsLatAm - #Colombia2024 ! Together, we delved into critical discussions, shared invaluable knowledge, and forged new connections that will drive the #biosimilars industry forward.
#Collaboration

How Humira biosimilars, when sourced from the right retailer and paying cash, can save payers and patients tens of thousands of dollars…

CVS Specialty has a prescribing guide for biosimilars for Humira #TeamCVS cvs.co/4aVzlfO

#festivalofbiologicsusa is underway!

Barry Chester (Pfizer Inc.) opens our 2024 edition with a discussion around Biosimilars and the ‘Challenges of Achieving Sustainbability in an Evolving Landscape’

Bring on day 1!

The future of #biosimilars (drugs made from living organisms) is at risk, even though these meds could drive $180 billion in projected savings over the next five years. We Work For Health weworkforhealth.org/_files/ugd/b11…

Unpacking alliances between biosimilar manufacturers and payers: A deep dive by ZS’s Biosimilars CoE bit.ly/3Q3uAIX

#biosimilars
biospace.com/article/sandoz…
Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies

Interview with FDA’s head of biosimilars:

FDA is ready to eliminate the interchangeability designation for biosimilars - endpts.com/fda-is-ready-t…

The top 10 immunology drugs generated ~$70 billion in revenue in '23. Some call outs:

1. Humira finally facing competition - there are now 9 biosimilars in the US.

2. Sanofi's Dupixent continued to hit records - new approval and positive phase 3 for COPD

3. J&J's Stelara will…

South Korean biosimilars are coming. Did you believe they would only come from Europe, Israel or India?

🎉 New #BeeWellWithMS Podcast Episode! Dive into 'Shaping the Future of MS Treatment: The Role of Generics and Biosimilars' with expert pharmacist Lucy Wessels. Uncover the potential of affordable treatments & empower your MS journey. 🌟 Listen now: beewellwithms.com…

The arrival of new immunology biosimilars is set to intensify competition in a rapidly expanding sector. Review historical and projected volume trends in our report: bit.ly/49EXw0V. #Biosimilars

ICYMI The Biosimilars Council's latest report uncovers #PBM barriers blocking your access to affordable medication. Learn more about the impact and potential solutions here:
biosimilarscouncil.org/news/pbm-rebat…

Taj Pharma is addressing global medical needs through a portfolio of differentiated & high quality, life-saving #biotherapeutics . We have used innovative science to bring competition for some of the world’s most expensive #medicines through our generics & biosimilars. ✨ #Oncology

CVS Specialty has a prescribing guide for biosimilars for Humira #TeamCVS cvs.co/3xCxRIQ